#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4342	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2324	549.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1819	1819	T	573	T	516	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4342	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2324	549.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1553	1553	C	661	C,G	572,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4342	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2324	549.2	0	HET	.	.	.	A922G,T	.	922	922	A	1291	1291	A	677	A,G,T	475,129,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6686	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3955	507.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1858	1858	A	616	A	542	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6686	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3955	507.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2492	2492	C	624	C,T	538,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6686	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3955	507.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2566	2566	A	643	A,T,C	554,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6686	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3955	507.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3118	3118	C	600	C	506	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6686	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3955	507.4	0	HET	.	.	.	C669T,A	.	669	669	C	1190	1190	C	542	C,T,A	361,101,1	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	688	folP	852	852	99.88	folP.l15.c17.ctg.1	1895	108.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	120.2	1	SNP	p	S91F	0	.	.	271	273	TCC	732	734	TCC	137;136;136	T;C;C	121;121;120	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	120.2	1	SNP	p	D95G	0	.	.	283	285	GAC	744	746	GAC	135;134;134	G;A;C	121;119;119	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	120.2	1	SNP	p	D95N	0	.	.	283	285	GAC	744	746	GAC	135;134;134	G;A;C	121;119;119	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	534	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1622	98.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	606	608	ACC	165;165;166	A;C;C,A	139;137;139,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	534	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1622	98.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	804	806	CAC	155;156;156	C;A;C	138;140;141	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	534	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1622	98.9	0	.	p	.	0	E117K	NONSYN	349	351	GAA	840	842	AAA	150;152;151	A;A;A	138;137;139	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	534	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1622	98.9	1	SNP	p	G45D	0	.	.	133	135	GGC	624	626	GGC	170;170;171	G;G;C,T	140;139;139,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	402	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1288	93.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1827	1829	GCA	141;141;140	G;C;A	129;129;125	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2310	2312	ATT	119;120;122	A;T;T	104;105;102	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	1	SNP	p	D86N	0	.	.	256	258	GAC	780	782	GAC	151;151;151	G;A;C	127;120;127	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	1	SNP	p	S87I	0	.	.	259	261	AGT	783	785	AGT	150;152;152	A;G;T	124;129;128	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	1	SNP	p	S87R	0	.	.	259	261	AGT	783	785	AGT	150;152;152	A;G;T	124;129;128	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	1	SNP	p	S87W	0	.	.	259	261	AGT	783	785	AGT	150;152;152	A;G;T	124;129;128	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1320	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3357	118.0	1	SNP	p	S88P	0	.	.	262	264	TCC	786	788	TCC	151;152;152	T;C;C	131;129;131	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1252	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3004	125.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1739	1741	GGC	173;175;174	G;G,T,A;C	148;148,1,1;152	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1458	1460	GCA	177;176;175	G;C;A	144;142;141	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1461	1463	ATC	175;174;175	A;T;C	148;144;146	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1473	1475	GTG	174;174;174	G;T;G	141;142;143	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1473	1475	GTG	174;174;174	G;T;G	141;142;143	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1977	1979	ACC	151;152;152	A;C;CGG,CG	133;136;113,1	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2031	2033	GCG	155;153;154	G;C;G,C	128;115;123,1	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2031	2033	GCG	155;153;154	G;C;G,C	128;115;123,1	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2154	2156	GGT	141;141;141	G;G;T	114;122;117	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2163	2165	GGC	140;140;140	G;G;C	118;119;117	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1128	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2755	122.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2181	2183	CCG	139;139;140	C,A,T;C;G	113,1,1;115;115	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1448	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3386	128.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	704	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2121	99.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	728	728	C	131	C	108	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	712	714	CAA	149;149;150	C;A;A	133;130;133	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	E212G	NONSYN	634	636	GAA	919	921	GGT	153;154;154	G;G;T	138;136;137	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	H213D	NONSYN	637	639	CAT	922	924	GAT	155;156;155	G;A;T	133;139;139	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	V215A	NONSYN	643	645	GTT	928	930	GCT	158;160;158	G;C;T	140;143;140	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	I218M	NONSYN	652	654	ATC	937	939	ATG	160;160;162	A;T;G	138;140;142	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1054	1056	AAG	158;157;158	A;A;G	140;139;137	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	776	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1550	141.3	1	SNP	p	G120K	0	.	.	358	360	GGC	643	645	GGC	162;162;163	G;G;C,A	137;133;133,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2666	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5156	155.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2171	2173	CAT	156;154;155	C;A;T	138;141;143	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	438	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1263	103.9	1	SNP	p	V57M	0	.	.	169	171	GTG	664	666	GTG	175;174;174	G;T;G,C	152;151;151,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
